This session will examine key policies in the areas of early detection screening, access to treatments, and areas of financial toxicity that have a direct impact on the prostate cancer racial disparity. Existing Policies will be examined from the perspectives of how they impact on the disparity, and how to make them more responsive to eliminating the disparity.

Session I Program

Watch Video     Moderator: J. Jacques Carter, MD, MPH, Assistant Professor, Harvard Medical School

Watch Video     Welcome: Thomas A. Farrington, PHEN President and Founder

Watch Video     Remarks: U.S. Congressman Gregory Meeks, 5th District of New York

Watch Video     Celebrating 20 Years of Summit – Part I: Ms. Tomeeka Miller, PHEN Director of Communications

Watch Video     Why Early Detection Screening Policies and Guidelines Are Priority: Keith Crawford, MD, PhD, PHEN Director of Clinical Trials and Patient Education

Watch Video     Financial Barriers to Prostate Cancer Diagnosis: The Rising Impact of Out-of-Pocket Costs: Arnav Srivastava, MD, PhD, Urologic Oncology, The University of Michigan    Presentation Slides: 2024.09.04 – PHEN Talk v01

Watch Video     Overview of the Facilitating Innovative Nuclear Diagnostics (FIND) Act: Mr. Ira Goldman, VP of Government Affairs, Lantheus     Presentation Slides: FIND_Act_PHEN_Sept2024

Watch Video     Panel Discussion on Prostate Cancer Policy Initiatives and Needs – Federal and State: Moderator: Mr. Anthony “Tony” Hill, PHEN Policy Coordinator

• • Ms. Shonta Chambers, Executive Vice President of Health Equity Initiatives and Community Engagement, Patient Advocate Foundation (PAF)
  • State Representative Goffrey A. “GA” Hardaway Sr., 93rd District of Tennessee
  • State Representative Dontavius Jarrells, 1st District of Ohio
  • Mr. James Williams, Director of Federal Relations, American Cancer Society

Closing Remarks: Dr. J. Jacques Carter